# Phaarmasia Ltd (PHRMASI)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹88.65
Day Change: -0.43%
52W High: ₹131.75
52W Low: ₹26
Market Cap: ₹61 Cr

## Valuation
P/E: 3.44
P/B: 5.68
EPS: ₹26
Book Value: ₹15.72
Dividend Yield: 0%

## Returns
1Y Return: 210.51%

## Profitability
ROE: -50%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Phaarmasia Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Phaarmasia Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Announcement Under Reg-30_Clarification
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-21T07:15:19.543Z
Price History Updated: 2026-05-21T07:15:20.100Z
Latest Price History Date: 2026-05-21
Technicals Updated: 2026-05-21T07:15:20.100Z
Quant Updated: 2026-05-21T07:15:20.100Z
Sentiment Updated: 2026-05-21T07:15:20.100Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹17 Cr
Operating Profit: ₹-2 Cr (OPM -11.78%)
Net Profit: ₹-2 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2022: Rev ₹17Cr | PAT ₹-2Cr | OPM -11.78%
FY 2023: Rev ₹27Cr | PAT ₹-1Cr | OPM -6.92%
FY 2024: Rev ₹31Cr | PAT ₹-1Cr | OPM -3.8%

## Balance Sheet (FY 2022)
Total Assets: ₹21 Cr
Total Liabilities: ₹9 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/phrmasi
Disclaimer: For research and education only. Not investment advice.